Metformin decreases the plasma concentration of pro-atherogenic metabolite trimethylamine N-oxide in an experimental model of type 2 diabetes

  • Melita Vidējā (Speaker)

    Activity: Talk or presentation typesOral presentation

    Period24 Mar 2021
    Event titleRSU Research week 2021: Knowledge for Use in Practice
    Event typeConference
    LocationRīga, LatviaShow on map
    Degree of RecognitionInternational